nabilone
CHEBI:CHEBI_135574
Chemical Information
- Molecular Formula
- C24H36O3
- Molecular Mass
- 372.542
- Charge
- 0
- SMILES
- OC1=C2C3(C(C(OC2=CC(=C1)C(CCCCCC)(C)C)(C)C)(CCC(C3)=O)[H])[H]
- InChI
- InChI=1S/C24H36O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h13-14,18-19,26H,6-12,15H2,1-5H3
- InChIKey
- GECBBEABIDMGGL-UHFFFAOYSA-N
Alternative Names
- cesamet
- LY 109514
- LY-109514
Treatment Applications
-
Noonan syndrome 12View Disease →
DOID:0112170
-
nephrotic syndrome type 23View Disease →
DOID:0112266
-
nephrotic syndrome type 22View Disease →
DOID:0112268
-
Nijmegen breakage syndromeView Disease →
DOID:7400
Drug Classification
-
organic heterotricyclic compoundView Class →
CHEBI:26979
-
organooxygen compoundView Class →
CHEBI:36963
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 31447
- oboInOwl#hasDbXref
- Drug_Central:1862
- core#notation
- CHEBI:135574
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 31447
- oboInOwl#hasDbXref
- Drug_Central:1862
- oboInOwl#id
- CHEBI:135574
- core#notation
- CHEBI:135574
- rxcui
- 104885
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT
- listing_expiration_date
- 20241231
- route
- ORAL
- dosage_form
- CAPSULE
- dea_schedule
- CII
- active_ingredient_strength
- 1 kg/kg
- nui
- M0003267
- pharm_class_epc
- Cannabinoid [EPC]
- pharm_class
- Cannabinoids [CS]
- pharm_class_cs
- Cannabinoids [CS]
- marketing_start_date
- 20200309
- package_marketing_start_date
- 11-MAR-20
- labeler_name
- Purisys LLC
- manufacturer_name
- Bausch Health US LLC
- generic_name
- Nabilone
- product_ndc
- 0187-1231
- spl_id
- c8ba6520-445a-4934-85f4-6f706cb21585
- active_ingredient_name
- NABILONE
- package_ndc
- 0187-1231-50
- package_description
- 1 BOTTLE in 1 CARTON (0187-1231-50) / 50 CAPSULE in 1 BOTTLE
- brand_name
- Cesamet
- brand_name_base
- Cesamet
- application_number
- NDA018677
- unii
- 2N4O9L084N
- spl_set_id
- 83c7ac15-ece9-47de-b83c-d575544fa449
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#2_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_112677
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect3701
- owl#annotatedSource
- t104717
- owl#someValuesFrom
- t867096